No Data
Astellas Pharma To Go Ex-Dividend On March 28th, 2025 With 37 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Astellas Pharma(4503.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 37 JPY dividend per share. The ex-
The shareholding percentage of Astellas Pharma and its joint shareholders with Blackrock Japan has increased to 8.80%.
It has been revealed that the shareholding ratio of Astellas Pharma <4503.T> by Blackrock Japan and co-holders has increased. According to the large shareholding change report submitted by Blackrock Japan after the market close on the 19th, the shareholding ratio by Blackrock Japan and co-holders rose from 8.62% in the previous submission to 8.80%. The purpose of holding is for pure investment. The closing price on the 19th was 1,493.5 yen, up 9.5 yen from the previous day. Provided by Wealth Advisor.
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of Buy Conversion Stocks Market Code Stock Name Closing Price SAR Main Board <1333> Maruha Nichiro 3266 3033 <1375> Snow Country Maitake 11801138 <1801> Taisei Corporation 69986364 <1802> Obayashi Corporation 20561907 <1803> Shimizu Corporation 14001294 <1861> Kumagai Gumi 41453795 <1925> Daiwa House 50404892 <1928> Sekisui.
JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre
J.P. Morgan Remains a Hold on Astellas Pharma (ALPMF)
Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing
